Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells

This publication has 25 references indexed in Scilit:

• Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation
  Nature Reviews Cancer, 2007
• Statin Drugs and Risk of Advanced Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2006
• Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs
  Molecular Cancer Therapeutics, 2006
• Nuclear Ptdlns(3,4,5)P₃ signaling: An ongoing story
  Journal of Cellular Biochemistry, 2006
• Statins and cancer prevention
  Nature Reviews Cancer, 2005
• Class reunion: PTEN joins the nuclear crew
  Oncogene, 2005
• HMG‐CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage
  The FASEB Journal, 2004
• Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
  American Journal of Physiology-Heart and Circulatory Physiology, 2004
• Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
  Nature Medicine, 2001
• Simvastatin and Ca2+ Signaling in Endothelial Cells: Involvement of Rho Protein
  Biochemical and Biophysical Research Communications, 2001